Tissue plasminogen activator for treatment of fibrin in endophthalmitis

Can J Ophthalmol. 2001 Aug;36(5):269-71. doi: 10.1016/s0008-4182(01)80020-x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anterior Chamber / drug effects
  • Anti-Bacterial Agents
  • Cataract Extraction
  • Drug Therapy, Combination / therapeutic use
  • Endophthalmitis / drug therapy*
  • Endophthalmitis / microbiology
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / microbiology
  • Female
  • Fibrin / drug effects*
  • Fibrinolysis / drug effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Injections
  • Lens Implantation, Intraocular
  • Male
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / microbiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus / isolation & purification
  • Tissue Plasminogen Activator / therapeutic use*
  • Vitreous Body / microbiology

Substances

  • Anti-Bacterial Agents
  • Fibrinolytic Agents
  • Fibrin
  • Tissue Plasminogen Activator